FUNDAMENTALS
EdgeFII/DII
MEDANTAGlobal Health
₹1,480.20+0.13%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
MEDANTANSE · EquityHealthcare Services

Global Health

ISIN
INE474Q01031
Instrument key
NSE_EQ|INE474Q01031
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹1,480.20+1.90 · +0.13%
Day rangecircuit ₹1,184.20 – ₹1,776.20
1,472.20
1,509.30

as of 21/11/2026, 11:43:48 am

Open
₹1,476.00
Day high
₹1,509.30
Day low
₹1,472.20
Prev. close
₹1,478.30
Volume
2.65 L
VWAP
₹1,490.44

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

6 months · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M
1Y
5Y
MAX
Change · 6M
+19.35%
1,240.20 → 1,480.20
Period high
₹1,544.00
27/8/2026
Period low
₹1,153.00
2/6/2026
From high
-4.13%
+28.38% from low
Avg volume
2.57 L
3.26 Cr total
Volatility · ann.
29.2%
127 candles · 62 up / 65 down
20 Nov 2026O 1,476.00H 1,509.30L 1,472.20C 1,480.20Vol 2.65 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data127 rows of open, high, low, close and volumeShowHide
20 Nov 20261,476.001,509.301,472.201,480.20+0.28%37.102.65 L
19 Nov 20261,436.601,485.501,432.701,478.30+2.90%52.802.82 L
18 Nov 20261,444.201,467.901,424.001,436.60-0.53%43.901.27 L
17 Nov 20261,433.001,453.401,425.001,444.20+0.78%28.402.01 L
16 Nov 20261,454.901,459.501,426.001,433.60-1.46%33.501.35 L
13 Nov 20261,445.001,465.001,435.001,454.00+0.62%30.001.28 L
12 Nov 20261,435.901,454.701,431.301,439.70+0.26%23.402.20 L
11 Nov 20261,427.101,432.601,400.001,429.00+0.13%32.602.18 L
9 Nov 20261,396.001,439.301,390.801,427.10+2.23%48.502.33 L
8 Nov 20261,399.001,409.101,391.801,397.50-0.11%17.3010.2K

Historical price and volume data · Showing 1–10 of 127

1 / 13

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

64.97
Company
64.97
Sector
55.28

Worse than sector by 18%

P/B

Price ÷ book value per share

9.21
Company
9.21
Sector
3.05

Worse than sector by 202%

ROA

Net income ÷ total assets

9.28%
Company
9.28%
Sector
4.2%

Better than sector by 121%

ROE

Net income ÷ shareholders' equity

14.3%
Company
14.3%
Sector
-31.98%

Better than sector by 145%

ROCE

EBIT ÷ capital employed

16.02%
Company
16.02%
Sector
11.89%

Better than sector by 35%

Quick Ratio

Liquid assets ÷ current liabilities

2.54
Company
2.54
Sector
32.98

Worse than sector by 92%

EV/EBITDA

Enterprise value ÷ EBITDA

33.48
Company
33.48
Sector
23.22

Worse than sector by 44%

04/Business

About the company

Sector: Healthcare Services

Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.

Sector market cap (INR)
₹39,829 Cr

reported in crore

Sector market cap (USD)
$4.43B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹4,509 Cr
+19.56% vs Mar 2025
Net profit · Mar 2026
₹554 Cr
+15.11% vs Mar 2025
Operating margin
15.9%
was 17.2%
Revenue CAGR · 4p
17.8%
profit 19.3% · op 16.8%
Filed order
Revenue4,5093,7713,3502,759
Revenue growthreported19.6%12.6%21.4%—
Operating profit715647627449
Operating profit growthreported10.5%3.2%39.6%—
Operating marginderived15.9%17.2%18.7%16.3%
Net profit554481478326
Net profit growthreported15.1%0.7%46.6%—
Net marginderived12.3%12.8%14.3%11.8%
EPS — basic₹/share, annual20.7117.9217.8012.58

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹5,905 Cr
+23.89% YoY
Total liabilities
₹1,921 Cr
Net worth
₹3,984 Cr
Liabilities ÷ assets
32.5%
lower means a lighter balance sheet
Filed order
Total assets5,9054,7664,3044,116
Total liabilities1,9211,3791,3981,688
Net worthderived3,9843,3882,9062,428
Liabilities ÷ assetsderived32.5%28.9%32.5%41.0%
Asset growthderived23.9%10.7%4.6%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets4,2303,2332,7952,536
Current Assets1,6751,5331,5091,579
Total Assets5,9054,7664,3044,116
Current Liabilities627619618573
Net Current Asset1,0489148911,007
Non-Current Liabilities1,2947607811,115
Equity Capital3,9843,3882,9062,428
Total Equity & Liabilities5,9054,7664,3044,116

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹714 Cr
+14.53% YoY
Investing
-₹1,089 Cr
Financing
₹272 Cr
Free cash flow
-₹375 Cr
operating + investing
Filed order
Operating activities714624612645
Operating changereported14.5%1.9%-5.0%—
Investing activities-1,089-721-441-342
Investing changereported-51.1%-63.5%-28.8%—
Financing activities272-97-514346
Financing changereported379.6%81.1%-248.7%—
Net cash flowderived-103-194-343648
Free cash flowoperating + investing-375-97171302

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax715647627449
Income before WC changes919888835648
Change in Assets-152-108-63-8
Change in Liabilities67818111
Change in WC-85-100-46103
Cash flow from Operations714624612645
Cash flow from Investing-1,089-721-441-342
Cash flow from Financing272-97-514346
Total Cash Flow-103-194-343648
Cash (Start of the year)230425767119
Cash (End of the year)127230425767

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
33.00%
0.00 pts QoQ
FII
9.91%
+0.45 pts QoQ
DII (other)
1.03%
+0.17 pts QoQ
Mutual funds
15.97%
-0.06 pts QoQ
Retail & others
40.09%
-0.56 pts QoQ
Filed order
Promoters33.0%33.0%33.0%33.0%
FII9.9%9.5%10.2%10.5%
DII (other)1.0%0.9%0.8%0.9%
Mutual funds16.0%16.0%13.9%13.1%
Retail & others40.1%40.6%42.1%42.5%
Promoters — QoQ changepts, derived0.0%-0.0%0.0%—
FII — QoQ changepts, derived0.4%-0.7%-0.4%—
DII (other) — QoQ changepts, derived0.2%0.0%-0.0%—
Mutual funds — QoQ changepts, derived-0.1%2.1%0.8%—
Retail & others — QoQ changepts, derived-0.6%-1.4%-0.4%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

DividendFinal₹0.5025.0%14 Aug 202614 Aug 202614 May 2026

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue4,4103,6923,2752,710
Other Income99797549
Total Revenue4,5093,7713,3502,759
Total Expenses3,7933,0742,7232,310
Profit Before Tax715647627449
Tax161166149123
Profit After Tax554481478326
EPS - Basic20.7117.9217.8012.58
EPS - Diluted20.6617.9217.8012.57

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.